Vivos Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2022 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Vivos Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2022 to 2024.
  • Vivos Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $153K.
  • Vivos Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $613K, a 1.83% increase from 2023.
  • Vivos Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $602K, a 37.4% increase from 2022.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $613K +$11K +1.83% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $602K +$164K +37.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $438K Jan 1, 2022 Dec 31, 2022 10-K/A 2024-07-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.